Take Action on World Hepatitis Day with Our Infectious Disease Combo Test
World Hepatitis Day is recognized every year on July 28 as a global call to action to fight against hepatitis and raise awareness of the importance of testing, prevention, and treatment. With millions of people still unaware that they are living with hepatitis B, hepatitis C, or other infectious diseases, early diagnosis remains the most effective way to prevent transmission and reduce long-term complications. Our solution to this ongoing public health challenge is the infectious disease combo test—a reliable, efficient, and affordable tool that enables rapid screening for multiple infections in one simple procedure.
The infectious disease combo test detects four major diseases: hepatitis B surface antigen, hepatitis C antibody, HIV 1/2 antibodies, and syphilis antibodies. Each test card is individually packaged and easy to use, requiring only a small blood sample and producing results within 15 minutes. As a point-of-care infectious test, Diabench is designed for use in clinics, field screenings, outreach programs, and mobile health units. The test does not require any additional instruments or electricity, making it ideal for low-resource settings or remote areas. Its portability and simplicity allow healthcare providers and NGO teams to screen large populations quickly and accurately.
One of the key components of this combo kit is the hepatitis B rapid test, which helps identify individuals infected with HBV. This is especially important in areas where hepatitis B is endemic and transmission risk is high. In parallel, the HIV rapid test kit included in the panel allows for fast detection of HIV 1 and 2 antibodies, a critical step in reducing late diagnosis and improving access to early treatment. By integrating both tests into a single platform, our infectious disease combo test simplifies the screening process, saves time, and reduces overall testing costs.
Unlike complex laboratory diagnostics, this point-of-care infectious test can be administered by trained community health workers or clinic staff with minimal training. Its accuracy and speed have made it a valuable tool in several health programs across African countries, where the product is certified and approved for use. Although it does not carry CE marking, it meets local standards and regulatory requirements in various African regions, ensuring reliable performance in real-world environments.
Healthcare initiatives, government projects, and humanitarian organizations have already begun using our hepatitis B rapid test and HIV rapid test kit to support disease control and awareness campaigns. Our manufacturing team also offers OEM and private labeling services to meet specific partner needs. We ship globally and support bulk purchasing for organizations looking to scale their outreach.
As World Hepatitis Day reminds us, testing is the first step in stopping the spread of infection. If your organization is seeking a trusted supplier of point-of-care infectious test kits, our infectious disease combo test is a proven solution. Contact us today to request samples, discuss pricing, or start a partnership that promotes faster diagnosis and better public health outcomes.
